phenyl acetate has been researched along with HMN (Hereditary Motor Neuropathy) Proximal Type I in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, C; Bertini, E; Mazzoni, E; Merlini, L; Minetti, C; Mongini, T; Morandi, L; Solari, A; Vita, G | 1 |
| Barohn, R; Bradley, W; Bryan, W; Dronsky, V; Gelinas, DF; Iannaccone, S; Kissel, J; Leshner, R; Mendell, J; Mendoza, M; Miller, RG; Moore, DH; Prior, TW; Russman, B; Samaha, F; Smith, S | 1 |
2 trial(s) available for phenyl acetate and HMN (Hereditary Motor Neuropathy) Proximal Type I
| Article | Year |
|---|---|
Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study.
Topics: Acetates; Adolescent; Adult; Amines; Arm; Child; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Isometric Contraction; Italy; Leg; Male; Middle Aged; Movement; Muscle, Skeletal; Neuroprotective Agents; Spinal Muscular Atrophies of Childhood; Treatment Outcome; Vital Capacity | 2003 |
A placebo-controlled trial of gabapentin in spinal muscular atrophy.
Topics: Acetates; Adult; Amines; Arm; Cyclohexanecarboxylic Acids; Double-Blind Method; Excitatory Amino Acid Antagonists; Feasibility Studies; Female; Gabapentin; gamma-Aminobutyric Acid; Hand Strength; Humans; Male; Muscle Contraction; Severity of Illness Index; Sickness Impact Profile; Spinal Muscular Atrophies of Childhood; Treatment Outcome; United States; Vital Capacity | 2001 |